# Efficacy and Safety Study of BF2.649 in the Treatment of Excessive Daytime Sleepiness in Narcolepsy

> **NCT01067222** · PHASE3 · COMPLETED · sponsor: **Bioprojet** · enrollment: 110 (actual)

## Conditions studied

- Narcolepsy
- Excessive Daytime Sleepiness
- Cataplexy
- Sleep Disorders

## Interventions

- **DRUG:** BF2.649
- **DRUG:** Modafinil
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01067222
- **Lead sponsor:** Bioprojet
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2010-07
- **Final completion:** 2010-12
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2012-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01067222

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01067222, "Efficacy and Safety Study of BF2.649 in the Treatment of Excessive Daytime Sleepiness in Narcolepsy". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01067222. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*